DR. MICHAEL H. PFEIFFER  THE CON- BECOMING A FAKE PHYSICIAN
Playing Dangerous Games with Lives

CON - DRUG SCIENTIST

RESEARCH DEGREE (PHD) IN NEUROPHYSIOLOGY /                                                                          HUMAN EXPERIMENTAL DRUG RESEARCHER / SCIENTIST

Mr. Michael H. Pfeiffer conducted a full schedule of research for 6 years at the institute of physiology and neuroscience laboratory at Charite Hospital at Humboldt University in Berlin at the same time that he claims to have been a full time medical student at the same university.

1994-1999

PhD (Research Degree), May 1999, from Laboratory of Professor Dr. Uwe Heinemann Institute of Physiology at the Medical Faculty of Charité, Humboldt University,  Berlin, Germany         

"Neuronal and gilal GABA-transporter and and their junction in the transition form pharmacosensitive to pharmacoresistant forms of epileptiform activity in the
temporal lobe of the rat in vitro."



Pfeiffer, M
., Draguhn, A., Meierkord, H. & Heinemann, U. (1996). Effects of gamma-aminobutyric acid (GABA) agonists and GABA uptake inhibitors on pharmacosensitive and pharmacoresistant epileptiform activity in vitro. British Journal of Pharmacology 119(3):569-77.

Source Abt. Neurophysiologie, Humboldt-Universität zu. Berlin, Germany; British Journal of Pharmacology 1996 Oct;119(3):569-77. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1915701/?tool=pubmed) 

PhD Research Source of funds: Deutche Forschungsgemeinschaft (DFG) The German Research Council - Research Collaboration Center - no. SBF 506

Abstract: Lowering of the extracellular Mg(2+)-concentration induces various patterns of epileptiform activity in combined rat entorhinal cortex-hippocampal brain slices. After a prolonged period of exposure to Mg(2+)-free medium seizure-like events in the entorhinal cortex change to a state of late recurrent discharges which cannot be blocked by clinically available antiepileptic drugs. This late epileptiform activity thus represents a useful model to test the effects of new anticonvulsant substances. 2. A mechanism possibly underlying the development of sustained seizure-like activity is the loss of synaptically released gamma-aminobutyric acid (GABA). Drugs which increase the amount of GABA available in presynaptic endings might thus be useful in the treatment of these therapeutically complicated forms of epilepsy. 3. Therefore, we studied the effects of various substances increasing GABA-mediated inhibition on early and late forms of epileptiform activity.  GABA and the GABAA receptor agonist muscimol blocked both the pharmacosensitive discharges in the hippocampus and entorhinal cortex as well as the late recurrent discharges in the medial entorhinal cortex. The GABAB receptor agonist baclofen blocked the recurrent short discharges very potently, but did not consistently block seizure-like events and late recurrent discharges in the entorhinal cortex. 4. GABA uptake blockers showed a differential potency to block the various discharge patterns. Whereas nipecotic acid and beta-alanine suppressed all forms of epileptiform activity albeit at high concentrations (1-5 mM), tiagabine was much more potent in blocking the hippocampal recurrent short discharges and the seizure-like events in the medial entorhinal cortex, but could not block the late recurrent discharges. 5. Our data support the idea that prolonged neuronal overactivity might result in a loss of synaptically available GABA. Selective block of uptake into glia cells or substitution of the transmitter may therefore be an efficient strategy for the treatment of severe prolonged epileptic discharges whereas block of neuronal GABA uptake fails to counteract synchronized discharges in this situation.    


Note: Michael H Pfeiffer Research -  German Research Collaboration Grant 506 (1997-2003) given to Prof. Dr. med Peter T. Daniel Director Molecular Hematology and Oncology, Charité - Humboldt University Campus Berlin, Germany
Publication: Cell Death and Differentiation (2003) 10, 461–467. Combined p53/Bax mutation results in extremely poor prognosis in gastric carcinoma with low microsatellite instability Edited by V De LaurenziA Mrózek1, H Petrowsky 3, I Sturm1, J Kraus2, S Hermann1, S Hauptmann2, M Lorenz3, B Dörken1 and Peter T Daniel, German Research Grant SBF 506    



Research Student Scholarship 1996
Student Scholarship - October 01,1995 to February 28,1996
  
Medical Faculty, Humboldt University Berlin Graduate Program
March 01 to December 31,199
6

Mechanisms of Damage in CNS 
Disease -
Application of Imaging Techniques"
Medical Faculty, Humboldt University Berlin


Research Presentations 1996

Congress of the Society of Neuroscience in Berlin, Germany,1996: 'Effects of GABA uptake inhibitors  on different patterns of low magnesium induced epileptiform activity in rat entorhinal cortex-hippocampal slices" in Symposium: "Entoriiinal-hippocampal interactions: From cellular mechanisms to clinical aspects"

Meeting of the Graduate Program "Mechanisms of Damage in CNS Disease - Application of Imaging Techniques" in Eggsdorf, Germany,1996:

'Effects of GABA-receptor agonists and of GABA-uptake inhibitors on different forms of epileptiform discharges in combined brain slices of rats in the low-magnesium model of temporal lobe epilepsy"

Mr. Pfeiffer’s Thesis records from the German National Library show he did receive a PhD. 

Strong evidence indicates that Michael Herbert Pfeiffer is trained as a human experimental drug researcher/ scientist (PhD in medical neurophysiology) from the Institute of Physiology (Neurophysiology) in the Medical School at Charite,  Humboldt University Hospital. He who has used people in the USA misunderstanding of the German educational and medical systen background to falsely receive a medical license for practicing medicine without proper medical training credentials.

PhD RESEARCH PUBLICATIONS                    1996-1999

“Look for Publications of M. Pfeiffer in PubMed”

Journals with Michael Pfeiffer's Research
(Full publications below to download)

European Journal of Pharmacology (1999)

British Journal of Pharmacology (1996,1999,2000)

Nervenartz- "Drug Research" (1999)

Naunyn-Schmiedeber's Archives of Phamracology (1999)

Journal of Neuroscience Methods (1997)

_______________________

The PhD Research  leading up to the PhD in 1999 and the publication of its research paper from 1996-1999. 

Pfeiffer, M., Draguhn, A., Meierkord, H. & Heinemann, U. (1996). Effects of gamma-aminobutyric acid (GABA) agonists and GABA uptake inhibitors on phamacosensitive and phamacoresistant epileptiform activity in vitro. British Journal of Pharmacology  119 (3): 569-77.

Draguhn, A., Pfeiffer, M., Heinemann, U. &Polder, R. (1997). A simple hardware model for the direct observation of voltage-clamp performance under realistic conditions. Journal of Neuroscience Methods 78 (1-2):105-13.

Meierkord, H., Griinig, P., Gutschmidt, U., Gutienez, R., Pfeiffer, M., Draguhn, A., Briickner, C. & Heinemann, U. (1999). Sodium bromide: effects on different patterns of epileptiform activity, extracellular pH changes and GABAergic inhibition. Naunyn Schmiedebergs Archives of Pharmacology 361 (1):25-32.

Holtkamp, H., Pfeiffer, M., Buchheim, K. & Meierkord, H. (1999). Tiagabin und nontonvulsiver Status epilepticus (Tiagabine and nonconvulsive tatus epilepticus). Newenarzt (Drug Research) 70 (12). 1104-1106.

Sabau. A., Frahm, C., Pfeiffer, M., Breustedt, 1.-M., Piechotta, A., Numberger, M., Engel, D., Heinemann, U. & Draguhn , A. (1999). Age Dependence of the anticonvulsant effects of the GABA uptake inhibitor tiagabiie in vitro. European Journal of Pharmacology, 383 (3), 259-266.


Sleziki KI, Cho YW, Yi SD, Brock MS, Pfeiffer MH, Mcvearry KM, Tractenberg RE, Motamedi, GK (2009).  Department of Neurology, Georgetown University Medical Center, Washington, DC, USA. Incident of atypical handedness in epilepsy and its association with clinical factorsEpilepsy Behaviour, 2009 Oct. 16(2):330-4. Epub 2009 Aug 28. PMID: 19716770. 

THE CON– REINVENTING – FROM SCIENTIST TO FAKE PHYSICIAN


Born 18 February 1963 in Nuremberg, Germany. 

Home base:  Pettenkoffer str. 5, Bayreuth, Germany

Father: Dr. rer pol. Johann Michael Pfeiffer, President E-On International Division (retired).

Mother: Margarite Wilhemine Pfeiffer (Garruth)

Brother: Detlef Georg Pfeiffer  Child

Diagnosis: "Autism"

1982 Graduated High School Gymnasium Christian-Ernestinum Bayreuth, Germany

1983-1984 Military Service 

1985/1985 Entered University for Engineering - did not finish; studies interrupted for 1-2 years. Must move back home with parents in Bayreuth, Germany.

1
990-1991 Semmelweis University Medical School, Budapest Hungary (September 1990 to April 1991 - (2 years  of 6 year program) "left, no progress"

1992-1994 Students of the French Language, 1st Degree Study; Ministry of National Education of France.    Diploma for Students of the French Language, 1st Degree, Ministry of National Education of France, June 1994, Berlin

1994-1999 P hD in Neurophysiology granted from The Johannes-Müller-Institut für Physiologie der Charité, Humboldt-Universität zu Berlin  (The Institute of Physiology at the Medical Faculty of Charite, Humboldt University, Berlin) , Germany

1994 September: Start as PhD Student – Year 1 Programme at Johannes-Müller-Institut für Physiologie der Charité, Humboldt-Universität zu Berlin Charite uner Uwe Heinmann, Physiology Institute,

1994 - Year 1 - PhD Student Institute for Physiology


1995 - 
Year 2- PhD Research Charite, Experimental Physiology Institute, under Dr. Uwe Heinmann

01 October 1995 to December 1995 Graduate Student Scholarship
 


1996 - Year 3 - The Active Student Researcher Year

PhD Student – Year 3- Programme at Charite uner Uwe Heinmann, Physiology Institute,

1 January to 28 February 1996; Student Scholarship, Medical Faculty, Humboldt University Berlin

1 March 1996 to 31 December 1996; Graduate Scholarship, Graduate Program “Mechanisms of Damage in CNS Disease - Application of Imaging Techniques” (see Note: NeuroCure)

Meeting of the Graduate Program Presentation: “Mechanisms of Damage in CNS Disease – Application of Imaging Techiques“ in Eggsdorf, Germany, 1996: „Effects of GABA-receptor agonists and of GABA-uptake inhibitors on different forms of epileptiform discharges in combined brain slices of rats in the low-magnesium model of temporal lobe epilepsy“.

Congress of the Society of Neuroscience in Berlin, 1996: Presentation: “Effects of GABA uptake inhibitors on different patterns of low magnesium induced epileptiform activity in rat entorhinal cortex-hippocampal slices” in Symposium: Entorhinal-hippocampal interactions: From cellular mechanisms to clinical aspects

Pfeiffer, M., Draguhn, A., Meierkord, H. & Heinemann, U. (1996). Effects of gamma-aminobutyric acid (GABA) agonists and GABA uptake inhibitors on pharmacosensitive and pharmacoresistant epileptiform activity in vitro. British Journal of Pharmacology 119(3):569-77. 

1996-1999  PhD Research publications from Humboldt University, Berlin, Germany

2000  Germany to the USA- CV Claims he was award of MD/PhD degree in 1998, but     no joint MD/PhD program until 2002.


2001-2003  
Research Fellow, Baylor College of Medicine, Neuroscience Laboratory, Houston, Texas

2003-2004   Internal Medicine Resident,  St. Francis Medical Center, Trenton, NJ

2004-2007  Neurology Resident, Georgetown University Medical Center, Washington, DC 20007

Children’s National Medical Center, Washington, DC

Washington Hospital Center           Washington, DC

Veterans Administration Medical Center, Washington, DC

National Institute of Health Stroke Unit, Washington, DC


2007-2008   “Neurology Fellowship”    

Mr. Pfeiffer practices of medicine at Georgetown University Medical Center Department of Neurology without a medical license. 

Web Hosting Companies